Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.38
- Piotroski Score 8.00
- Grade Buy
- Symbol (PKI)
- Company PerkinElmer, Inc.
- Price $115.24
- Changes Percentage (-0.91%)
- Change -$1.06
- Day Low $114.67
- Day High $117.21
- Year High $170.00
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
- Last Earnings 04/25/2023
- Ex-Dividend for 5/16 Dividend 07/20/2023
- Dividend Payable 08/11/2023
- Today N/A
- Next Earnings (Estimated) 07/31/2023
- Fiscal Year End N/A
- Average Stock Price Target $164.00
- High Stock Price Target $202.00
- Low Stock Price Target $145.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $2.78
- Trailing P/E Ratio 41.453237410072
- Forward P/E Ratio 41.453237410072
- P/E Growth 41.453237410072
- Net Income $579.18 M
Income Statement
Quarterly
Annual
Latest News of PKI
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Philadelphia students launch pumpkins into farm field to promote composting
Students in Philadelphia are repurposing discarded pumpkins to reduce waste by creating pumpkin launchers for composting. The initiative aims to recycle pumpkins and educate the public while having fu...
By CBS News | 1 day ago -
Gardner-Webb hosts Elon following Simpkins' 21-point game
Elon faces Gardner-Webb after a strong performance by TJ Simpkins. Gardner-Webb had a 17-16 record with solid stats like 5.9 steals per game. In contrast, Elon struggled with a 13-19 record, allowing ...
By AP NEWS | 1 day ago -
DeAndre Hopkins already a difference-maker for the Chiefs and GM Brett Veach
The Chiefs' acquisition of DeAndre Hopkins has been a game-changer, with his leadership, performance, and impact on the team evident just weeks after joining. His chemistry with Mahomes and ability to...
By The New York Times | 2 days ago
